The Drug oral bioavailability is the fractional extent of a drug dosage that finally reaches to the therapeutic site of action and it is quantitatively symbolized as %F. In many cases, most of the orally administered drug is metabolized and eliminated before reaching systemic blood circulation. Therefore, poor bioavailability may cause a new drug to fail clinical trials, even if it has high efficacy in previous in vitro and/or in vivo tests. The traditional process for measuring the %F of a drug is expensive, costly, and time-consuming. Using computational methods as an alternative to calculating the %F of new drug candidates, even before synthesizing the compound, would be advantageous by saving resources and provides a promising alternative to traditional experimental protocols.
Research: Pharmacoeconomics: Open Access
Research: Pharmacoeconomics: Open Access
Commentary: Pharmacoeconomics: Open Access
Commentary: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Journal of Bioprocessing & Biotechniques
Scientific Tracks Abstracts: Journal of Bioprocessing & Biotechniques
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters-Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters-Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 